Navigation Links
Big brains arose twice in higher primates
Date:7/9/2008

After taking a fresh look at an old fossil, John Flynn, Frick Curator of Paleontology at the American Museum of Natural History, and colleagues determined that the brains of the ancestors of modern Neotropical primates were as small as those of their early fossil simian counterparts in the Old World. This means one of the hallmarks of primate biology, increased brain size, arose independently in isolated groupsthe platyrrhines of the Americas and the catarrhines of Africa and Eurasia.

"Primatologists have long suspected that increased encephalization may have arisen at different points in the primate evolutionary tree, but this is the first clear demonstration of independent brain size increase in New and Old World anthropoids," says Flynn of the paper that appeared in the Museum's publication Novitates this June. Encephalization is the increase in brain size relative to body size. Animals with large encephalization quotients (E.Q.'s) are those with bigger brains relative to their body size in comparison to the average for an entire group. Most primates and dolphins have high E.Q.'s relative to other mammals, although some primates (especially apes and humans) have higher E.Q.'s than others.

At the heart of the new paper is the development of more accurate equations for estimating body size in platyrrhines, or New World "monkeys." Most fossils are fragments of skulls or teeth so, to help in estimating their body size (and then E.Q.), Flynn and colleagues collected 80 measurements of the skulls, jaws, and teeth of 17 different species of living New World monkeys that ranged across the full spectrum of body sizes. This study is one of the first to estimate body size with platyrrhines instead of their better-studied counterparts from the Old World, and this detailed analysis uses new statistical approaches to tease out which characteristics correlate best with body size. The goal is to apply this equation to fossilized specimens.


'/>"/>
Contact: Kristin Phillips
kphillips@amnh.org
212-496-3419
American Museum of Natural History
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Doctors learn to control their own brains pain responses to better treat patients
2. From brains to behavior: Cold Spring Harbor Protocols features methods for neuroscience research
3. Brains R Us: Neuroscience and education town hall
4. Girls who begin dieting twice as likely to start smoking
5. Risk of common vaginal infection linked to preterm birth appears higher for blacks
6. Improved e-jet printing provides higher resolution and more versatility
7. Low vitamin D linked to higher risk of hip fracture
8. Engineers study brain folding in higher mammals
9. Less Arctic ice means higher risks, experts warn
10. Obesity-related hormone is higher in children with Down syndrome
11. Insects take a bigger bite out of plants in a higher CO2 world
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Big brains arose twice in higher primates
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/km7m5t/natural_language ... "Natural Language Processing Market by Type (Rule-Based, Statistical, ... Image Recognition) - Worldwide Forecast to 2020" ... vendors occupying the market are 3M, Apple, Dolbey ... Solutions, SAS Institute Inc., Verint Systems among various ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... diseases are associated with defective proteins accumulating in ... mechanisms are not operating correctly. Now, researchers at ... discovered a molecular link between the cell’s two ... succeeded in using this link to rescue neurodegenerative ...
... Few older people die with brains untouched by a ... signs of dementia increases with the number of different ... new study. The research was funded by the National ... of Health, and conducted at the Rush Alzheimer’s Disease ...
... of the Roche group, and a Yale School of ... company’s Genome Sequencer™ system to identify previously undetectable rare ... performed clinical trial. The work, presented today by ... Medicine and the VA CT Health Care System, was ...
Cached Biology News:Penn researchers link cell's protein recycling systems 2Penn researchers link cell's protein recycling systems 3Study finds mix of disease processes at work in brains of most people with dementia 2454 sequencing identifies HIV drug resistance at early stage 2
(Date:7/30/2015)... Mass. , July 30, 2015   ... solutions for the interpretation and analysis of genomic ... Matthew Fischer has joined the company as ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... capabilities to integrate, interpret, analyze and explore complex ...
(Date:7/30/2015)... , July 30, 2015 ... by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, ... & Development, Preclinical, Clinical Trial), by End Users - ... Market is expected to reach USD 2,107.99 million by ... CAGR of 15.29%. Browse more than ...
(Date:7/30/2015)...   Senomyx , Inc. (NASDAQ: SNMX ), ... discover, develop, and commercialize novel flavor ingredients for the ... results for the second quarter 2015. ... on track to achieve our commercial and financial goals," ... the Company. "Since our last quarterly earnings report, our ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes are against ... were $697 million compared to $701 million in the ... and changes in foreign currency exchange rates decreased sales ... , By business unit, organic sales growth was 6% ... Commercial. , Reported diluted EPS was $0.98 compared ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... BOXMEER, The Netherlands and LONDON, September 26 ,Nobilon ... care business,unit of Akzo Nobel, and Protherics PLC, ... cancer, today announced that Nobilon,has licensed Protherics, CoVaccine ... seasonal influenza vaccines in elderly people. More ...
... Empowers Life Sciences Community with accelerated BioInformatics, ... Corp., announced,the initiation of Progeniq Pte Ltd, ... Singapore, into the BioIT Alliance today. The,BioIT ... integrate science and,technology to accelerate the pace ...
... Tomorrow, Wednesday, September 26th at 8:30am, NEW YORK, ... announced today that it will conduct a conference call,to ... II portfolio,products for a territory outside the US. ... 2007, at,8:30am EDT. Michael S. Weiss, Chairman and CEO ...
Cached Biology Technology:Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications 2Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications 3Progeniq Joins Microsoft in Bio IT Alliance 2Progeniq Joins Microsoft in Bio IT Alliance 3Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance 2
... CAST Equine EIA Principle: ... LTD4 and LTE4 are products ... 5-lipoxygenase and glutathione-S-transferase. In the ... "Slow Reacting Substances of Anaphylaxis ...
... contain the basic components and protocol ... ELISA plates for quantitation of a ... cell culture supernate. Every Screening Set ... Standard (5 individual standards), Streptavidin-HRP, TMB ...
... degradation is critical to the maintenance ... regulatory proteins as important and diverse ... heat shock and stress response, antigen ... and ion channels, cell cycle regulation, ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential GI liabilities of compounds....
Biology Products: